Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06588582 · ClinicalTrials.gov registry record · NA
Perceptual Influences From Smoking Cannabis: an Experimental Study
A NA study of Stress and Cannabis Use, sponsored by University of Colorado, Boulder.
- Recruiting
- Registry status
- NA
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT06588582: Recruiting NA study of Stress and Cannabis Use, sponsored by University of Colorado, Boulder.
NCT06588582 is a NA study of Stress and Cannabis Use that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 166 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06588582, a NA study of Stress and Cannabis Use, is actively recruiting participants, sponsored by University of Colorado, Boulder.
- RECRUITING
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to better understand the effects of cannabis in relation to mental and physical states including its relationship with mood, cognition, perception including the experience of temperature and pain, and heart rate. We expect that participants will be in this research study for approximately one week. The total amount of time that participants will spend completing study tasks will be about 2.5 hours across two separate in-person visits.
Primary Outcome
Cortisol levels are measured in blood.
Conditions Studied
Interventions
- OTHER Water Temperature Variation - WW
- OTHER Water Temperature Variation - CW
Study Locations (1)
Colorado
- University of Colorado at Boulder - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2025-02-17 |
| Est. Completion | 2029-07-31 |
| Phase | NA |
What NCT06588582 shows while recruiting
NCT06588582 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Water Temperature Variation - WW is the first listed.
NCT06588582 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06588582 about?
NCT06588582 is a clinical study titled "Perceptual Influences From Smoking Cannabis: an Experimental Study". The purpose of the study is to better understand the effects of cannabis in relation to mental and physical states including its relationship with mood, cognition, perception including the experience of temperature and pain, and heart rate. We expect that participants will be in this research study...
What is the current status of trial NCT06588582?
This trial is currently recruiting. It is a NA study. The enrollment target is 166 participants. The study started on 2025-02-17. Estimated completion is 2029-07-31.
What conditions does trial NCT06588582 study?
This clinical trial studies the following conditions: Stress, Cannabis Use.
What interventions are being tested in trial NCT06588582?
The interventions under investigation include: Water Temperature Variation - WW (OTHER), Water Temperature Variation - CW (OTHER).
Who is sponsoring clinical trial NCT06588582?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06588582 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06588582's enrollment target sits among peer trials
166 38th of 152 higher than 115 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI